Navigation Links
China Sky One Medical Inc. Gets SFDA Approval for Calcium Folinate Injection
Date:3/3/2009

HARBIN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it obtained production approval from the State Food and Drug Administration (SFDA) in China for Calcium Folinate Injection. Another two new traditional Chinese medicines, Paeonol gel and Mei Lu gel, were approved by SFDA to enter into clinical trials. All three are all prescription drugs.

Calcium Folinate Injection is a solution for injection intended as an auxiliary therapy for sprue (a disease of the small intestine), malnutrition, pregnancy- or infancy-related megaloblastic anemia, and colonic and rectal cancer. It will be available to consumers around June of 2009.

Paeonol gel is a type of anti-allergic, anti-pyretic and anti-itch medicine that can be used for the treatment of eczema, dermatitis and other kinds of skin diseases caused by insect bites. It can also be used to cure allergic rhinitis as well as for the prevention of colds. Mei Lu gel is used to treat Acne vulgaris and to relieve itching. It can also be used to cure other skin diseases, including eczema and dermatitis solaris, and repel insects. Clinical trials for the two gels will last approximately six months, and management expects to receive final SFDA approvals in 2010.

"We are very pleased to achieve such great progress in developing new drugs," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "All of these products have been developed to meet customers' needs. We expect them to perform well and to create value for consumers and shareholders alike."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Yu-Bo Hao, CFO
     Tel:   +86-451-5399-4069
     Email: china_sky_one@yahoo.cn

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

'/>"/>
SOURCE China Sky One Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Nepstar Chain Drugstore to Announce Fourth Quarter and Fiscal 2008 Financial Results on March 16
2. University of the Rockies Faculty and Students Travel to China to Share Western Philosophy
3. QSAI & SGS-CSTC to Begin Joint Food Analysis Services in China
4. China Sky One Medical, Inc. Exports Sumei Slim Patch to South Korea and Sudan
5. China Healthcare Acquisition Announces Record Date for Trust Fund Distribution
6. Hard To Treat Diseases (HTDS) Closes Acquisition of Mellow Hope, China
7. China YCT International Group, Inc. Announces Third Quarter Fiscal 2009 Results
8. China Shenghuo Receives Notice from NYSE Alternext US Regarding Listing Standards
9. China-Biotics, Inc. Reports Third Quarter 2009 Financial Results
10. Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board
11. China-Biotics, Inc. Announces Conference Call to Discuss Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz found ... she dedicated herself to meditation for its impact on her life, implementing a 20-minute-per-day ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher ... Military Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare ... System. This will be the first Fisher House in Nevada, and will provide ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one of ... of physicians establishing, leading and partnering with ambulatory surgery centers across the United States. ... also known as an ASC, is a modern health care facility focused on providing ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ procurement organization ... a partnership with San Ramon Regional Medical Center. Under the collaboration, the first of ... way to accommodate a more certain time frame for donor families for the recovery ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... OAKLAND, Calif. , Feb. 11, 2016  Walgreens ... stores across 39 states and Washington, D.C. ... in a move that was commended by shareholder advocacy organization ... President at As You Sow. "Many people hold on to ... options, which can have tragic consequences." --> ...
(Date:2/11/2016)... 2016  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and other birth tissues, human skin and bone, and ... advanced products and therapies, announced today that it will ... Conference in New York , NY.  ... J. Senken , Chief Financial Officer and Chris ...
Breaking Medicine Technology: